Sec. 242. BIOTECHNOLOGY ROADMAP

1,109 words·~5 min read·/statute-compilations/comps-18280/sec-242

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 242 BIOTECHNOLOGY ROADMAP ###

(a)Roadmap Required Not later than one year after the date of the enactment of this Act, the Secretary of Defense, in coordination with the Under Secretary of Defense for Research and Engineering, the Under Secretary of Defense for Acquisition and Sustainment, and the Secretaries of the military departments, shall submit to the congressional defense committees a biotechnology roadmap. ###

(b)Elements In the roadmap required by subsection (a), the Secretary of Defense shall— ####

(1)identify the strategic objectives of the Department of Defense relating to biotechnology; ####

(2)for each strategic objective, establish specific goals and milestones for the achievement of such objective, including timelines for meeting such goals and milestones; ####

(3)in the case of each updated version of the roadmap following submittal of the initial roadmap under subsection (a), include— #####

(A)a review of the goals and milestones established under paragraph

(2)to ensure such goals and milestones continue to align with strategic objectives under paragraph (1); and #####

(B)a description of any goals and milestones that changed as a result of such review; ####

(4)identify the biotechnology development needs and priorities for national security applications based on the strategic objectives identified in paragraph (1); ####

(5)assess the technology maturity of each priority identified pursuant to paragraph (4); ####

(6)describe funding sources for each priority identified pursuant to paragraph (4), including both current sources and sources covered by the future-years defense program submitted to Congress under section 221 of title 10, United States Code; ####

(7)provide a plan, timeline, and metrics for research, development, testing, and evaluation activities for the priorities identified pursuant to paragraph (4); ####

(8)assess opportunities for rapid acquisition and fielding of biotechnology in support of the priorities identified pursuant to paragraph (4); ####

(9)identify and describe the role of each organization of the Department with responsibilities relating to biotechnology under the strategy, including investment priorities for the Office of Strategic Capital and the Defense Advanced Research Projects Agency; ####

(10)assess the overall risk to the security of the United States of the biotechnology efforts covered by the strategy; ####

(11)analyze any requirements of the Federal Government that hinder the ability of the Department to advance and use biotechnology; ####

(12)provide for the development and support of the biotechnology workforce of the Department, including personnel with responsibilities relating directly to biotechnology and personnel who indirectly support the biotechnology efforts of the Department such as personnel involved program management, acquisition, investment, and legal matters; ####

(13)with respect to the biotechnology workforce described in paragraph (12)— #####

(A)identify the total number of biotechnology positions required to support the objectives of the roadmap— ######

(i)as of the date of the roadmap; and ######

(ii)over the periods of five and 10 years following such date; #####

(B)indicate the number of such positions that have been filled as of the date of the roadmap; #####

(C)describe the positions included in the biotechnology workforce, including a description of— ######

(i)the role of each position in supporting the objectives under paragraph (1); and ######

(ii)the qualifications required for each position, including any qualifications relating to seniority level, education, training, and security clearances; #####

(D)identify any challenges affecting the ability of the Department to develop the biotechnology workforce and propose solutions to those challenges; #####

(E)assess whether the codes used to define positions and roles within the workforce of the Department adequately cover the range of positions and personnel that comprise the biotechnology workforce, such as personnel in research, engineering, and testing; #####

(F)identify mechanisms to enable the Department to access outside expertise relating to biotechnology, including mechanisms to assemble a pool of outside experts who have been prequalified (including by obtaining any necessary security clearances) to provide advice and assistance to the Department on matters relating to biotechnology on an as-needed basis; and #####

(G)assess whether personnel occupying existing positions in the Department could be used to meet biotechnology workforce needs with additional training and, if so, the nature and scope of the training required; and ####

(14)address collaboration between the Department and international partners to advance research on biotechnology, which shall include— #####

(A)a description of any international partnerships under which the United States is collaborating with partners to conduct biotechnology research and development for defense purposes, including a description of any investment priorities for the Office of Strategic Capital and the Defense Advanced Research Projects Agency relating to such partnerships; #####

(B)a description of any new international partnerships that may be entered into, or existing partnerships that may be modified, to provide for such collaboration; and #####

(C)identification of any challenges affecting the ability of the Department engage in such collaboration with international partners, including— ######

(i)any limitations on co-investments within international partnerships; ######

(ii)any United States export controls or other technology protections that hinder information sharing within such partnerships; and ######

(iii)any other challenges that may prevent the full utilization of such partnerships for such collaboration. ###

(c)Biennial Updates Not less frequently than once every two years following the submittal of the initial roadmap under subsection

(a)until the termination date specified in subsection (h), the Secretary shall— ####

(1)review and update the roadmap; and ####

(2)submit an updated version of the roadmap to the congressional defense committees. ###

(d)Form Each version of the roadmap required to be submitted under this section may be submitted in classified form, but if so submitted, shall include an unclassified executive summary. ###

(e)Public Availability On annual basis, the Secretary shall make an unclassified version of the most recent roadmap submitted under this section available on a publicly accessible website of the Department of Defense. ###

(f)GAO Evaluation and Report Not later than 180 days after the date on which the Secretary of Defense submits the initial roadmap pursuant to subsection (a), the Comptroller General of the United States shall— ####

(1)complete an evaluation of the roadmap; and ####

(2)submit to the congressional defense committees a report on the findings of the Comptroller General with respect to such evaluation. ###

(g)Biotechnology Defined In this section, the term “biotechnology” means the application of science and technology to living organisms and to parts, products, and models of such organisms to alter living or non-living materials for the production of knowledge, goods, or services. ###

(h)Sunset This section shall terminate on the date that is 10 years after the date of the enactment of this Act.